Cargando…

A Model-Based Pharmacokinetic/Pharmacodynamic Analysis of the Combination of Amoxicillin and Monophosphoryl Lipid A Against S. pneumoniae in Mice

Combining amoxicillin with the immunostimulatory toll-like receptor 4 agonist monophosphoryl lipid A (MPLA) represents an innovative approach for enhancing antibacterial treatment success. Exploiting pharmacokinetic and pharmacodynamic data from an infection model of Streptococcus pneumoniae infecte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franck, Sebastian, Michelet, Robin, Casilag, Fiordiligie, Sirard, Jean-Claude, Wicha, Sebastian G., Kloft, Charlotte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065677/ https://www.ncbi.nlm.nih.gov/pubmed/33808396 http://dx.doi.org/10.3390/pharmaceutics13040469

Ejemplares similares

The Use of Translational Modelling and Simulation to Develop Immunomodulatory Therapy as an Adjunct to Antibiotic Treatment in the Context of Pneumonia
por: Michelet, Robin, et al.
Publicado: (2021)

Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
por: Seeger, Johanna, et al.
Publicado: (2021)

Therapeutic Synergy Between Antibiotics and Pulmonary Toll-Like Receptor 5 Stimulation in Antibiotic-Sensitive or -Resistant Pneumonia
por: Matarazzo, Laura, et al.
Publicado: (2019)

Pharmacokinetics and Pharmacodynamics of Tedizolid
por: Iqbal, Khalid, et al.
Publicado: (2022)

Pharmacokinetics/pharmacodynamics of lefamulin in a neutropenic murine pneumonia model with Staphylococcus aureus and Streptococcus pneumoniae
por: Wicha, Wolfgang W, et al.
Publicado: (2019)

Amoxicillin-resistant Streptococcus pneumoniae can be resensitized by targeting the mevalonate pathway as indicated by sCRilecs-seq
por: Dewachter, Liselot, et al.
Publicado: (2022)

Immuno-Stimulatory Activity of Escherichia coli Mutants Producing Kdo(2)-Monophosphoryl-Lipid A or Kdo(2)-Pentaacyl-Monophosphoryl-Lipid A
por: Wang, Biwen, et al.
Publicado: (2015)

Towards the Elucidation of the Pharmacokinetics of Voriconazole: A Quantitative Characterization of Its Metabolism
por: Schulz, Josefine, et al.
Publicado: (2022)

Specific features of human monocytes activation by monophosphoryl lipid A
por: Chentouh, Ryme, et al.
Publicado: (2018)

Monophosphoryl Lipid A Tolerance Against Chronic Stress-Induced Depression-Like Behaviors in Mice
por: Li, Fu, et al.
Publicado: (2022)

Pharmacokinetic/Pharmacodynamic Evaluation of Aztreonam/Amoxicillin/Clavulanate Combination against New Delhi Metallo-β-Lactamase and Serine-β-Lactamase Co-Producing Escherichia coli and Klebsiella pneumoniae
por: Zhang, Jiayuan, et al.
Publicado: (2023)

Inefficient TLR4/MD-2 Heterotetramerization by Monophosphoryl Lipid A
por: Casella, Carolyn R., et al.
Publicado: (2013)

Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines
por: Chen, Chen, et al.
Publicado: (2019)

Study on the CID Fragmentation Pathways of Deprotonated 4’-Monophosphoryl Lipid A
por: Aissa, Ibrahim, et al.
Publicado: (2021)

Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies
por: Alffenaar, Jan-Willem C., et al.
Publicado: (2022)

Safety, Pharmacokinetic, and Pharmacodynamic Study of a Sublingual Formula for the Treatment of Vasovagal Syncope
por: Hutson, Paul, et al.
Publicado: (2022)

Monophosphoryl lipid a attenuates radiation injury through TLR4 activation
por: Guo, Jiaming, et al.
Publicado: (2017)

Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines
por: Cheng, Ruoyu, et al.
Publicado: (2020)

Gemcitabine and doxorubicin in immunostimulatory monophosphoryl lipid A liposomes for treating breast cancer
por: Wu, Debra, et al.
Publicado: (2020)

Prediction of the Drug–Drug Interaction Potential between Tegoprazan and Amoxicillin/Clarithromycin Using the Physiologically Based Pharmacokinetic and Pharmacodynamic Model
por: Wei, Zhuodu, et al.
Publicado: (2023)

BACTOME—a reference database to explore the sequence- and gene expression-variation landscape of Pseudomonas aeruginosa clinical isolates
por: Hornischer, Klaus, et al.
Publicado: (2019)

Monophosphoryl Lipid a as an adjuvant for immune therapy? A detailed in vitro comparison to LPS
por: Schülke, Stefan, et al.
Publicado: (2014)

TLR4 Agonist Monophosphoryl Lipid A Alleviated Radiation-Induced Intestinal Injury
por: Guo, Jiaming, et al.
Publicado: (2019)

In vitro effects of monophosphoryl lipid A and Poly I:C combination on equine cells
por: Lee, Dong-Ha, et al.
Publicado: (2023)

Pharmacokinetic and pharmacodynamic evaluation of rivaroxaban: considerations for the treatment of venous thromboembolism
por: Harder, Sebastian
Publicado: (2014)

Pharmacokinetics and Pharmacodynamics of Nemonoxacin in a Neutropenic Murine Lung Infection Model Against Streptococcus Pneumoniae
por: Li, Xin, et al.
Publicado: (2021)

Synthesis of monophosphorylated lipid A precursors using 2-naphthylmethyl ether as a protecting group
por: Xue, Jundi, et al.
Publicado: (2020)

Pharmacokinetic/pharmacodynamic target attainment analyses to support intravenous and oral lefamulin dose selection for the treatment of patients with community-acquired bacterial pneumonia
por: Bhavnani, Sujata M, et al.
Publicado: (2019)

Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii
por: Song, Pengxia, et al.
Publicado: (2017)

Construction of Monophosphoryl Lipid A Producing Escherichia coli Mutants and Comparison of Immuno-Stimulatory Activities of Their Lipopolysaccharides
por: Han, Yaning, et al.
Publicado: (2013)

In Vitro Evaluation of the Biological Responses of Canine Macrophages Challenged with PLGA Nanoparticles Containing Monophosphoryl Lipid A
por: Guldner, Delphine, et al.
Publicado: (2016)

Monophosphoryl lipid A alleviated radiation‐induced testicular injury through TLR4‐dependent exosomes
por: Liu, Zhe, et al.
Publicado: (2020)

An improved PKPD modeling approach to characterize the pharmacodynamic interaction over time between ceftazidime/avibactam and colistin from in vitro time-kill experiments against multidrug-resistant Klebsiella pneumoniae isolates
por: Aubry, Romain, et al.
Publicado: (2023)

Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid
por: Lee, Soo-Yun, et al.
Publicado: (2015)

A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions
por: Wicha, Sebastian G., et al.
Publicado: (2017)

Translational Pharmacometric Evaluation of Typical Antibiotic Broad‐Spectrum Combination Therapies Against Staphylococcus Aureus Exploiting In Vitro Information
por: Wicha, SG, et al.
Publicado: (2017)

Impact of Albumin Binding Function on Pharmacokinetics and Pharmacodynamics of Furosemide
por: Klinkmann, Gerd, et al.
Publicado: (2022)

Microdialysis of Voriconazole and its N-Oxide Metabolite: Amalgamating Knowledge of Distribution and Metabolism Processes in Humans
por: Schulz, Josefine, et al.
Publicado: (2022)

Microdialysis of Drug and Drug Metabolite: a Comprehensive In Vitro Analysis for Voriconazole and Voriconazole N-oxide
por: Schulz, Josefine, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics of Posaconazole
por: Chen, Lu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kgbgdjbpp6f31npf8ujefmivo0